<VariationArchive VariationID="566399" VariationName="NM_000294.3(PHKG2):c.250del (p.Val84fs)" VariationType="Deletion" Accession="VCV000566399" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-14" DateCreated="2018-10-10" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="570252" VariationID="566399">
      <GeneList>
        <Gene Symbol="PHKG2" FullName="phosphorylase kinase catalytic subunit gamma 2" GeneID="5261" HGNC_ID="HGNC:8931" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16p11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="30748425" stop="30761176" display_start="30748425" display_stop="30761176" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="30759619" stop="30772496" display_start="30759619" display_stop="30772496" Strand="+" />
          </Location>
          <OMIM>172471</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000294.3(PHKG2):c.250del (p.Val84fs)</Name>
      <CanonicalSPDI>NC_000016.10:30751258:GG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16p11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="30751259" stop="30751259" display_start="30751259" display_stop="30751259" variantLength="1" positionVCF="30751258" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="30762580" stop="30762580" display_start="30762580" display_stop="30762580" variantLength="1" positionVCF="30762579" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>V84fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.30751260del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.30751260del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.30762581del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.30762581del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016616.2" sequenceAccession="NG_016616" sequenceVersion="2" change="g.7962del">
            <Expression>NG_016616.2:g.7962del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000294.3" sequenceAccession="NM_000294" sequenceVersion="3" change="c.250del" MANESelect="true">
            <Expression>NM_000294.3:c.250del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000285.1" sequenceAccession="NP_000285" sequenceVersion="1" change="p.Val84fs">
            <Expression>NP_000285.1:p.Val84fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001172432.2" sequenceAccession="NM_001172432" sequenceVersion="2" change="c.250del">
            <Expression>NM_001172432.2:c.250del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001165903.1" sequenceAccession="NP_001165903" sequenceVersion="1" change="p.Val84fs">
            <Expression>NP_001165903.1:p.Val84fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1567260747" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000294.3(PHKG2):c.250del (p.Val84fs) AND Glycogen storage disease IXc" Accession="RCV000686201" Version="4">
        <ClassifiedConditionList TraitSetID="3750">
          <ClassifiedCondition DB="MedGen" ID="C2751643">Glycogen storage disease IXc</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-04-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-04-25" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-10-10" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17689125</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21646031</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8896567</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3750" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6905" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Glycogen storage disease IXc</ElementValue>
                <XRef ID="MONDO:0013091" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GSD IXc</ElementValue>
                <XRef Type="MIM" ID="613027" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GSD9C</ElementValue>
                <XRef Type="MIM" ID="613027" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18387" />
                <XRef ID="18387" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Phosphorylase kinase (PhK) deficiency causing glycogen storage disease type IX (GSD IX) results from deficiency of the enzyme phosphorylase b kinase, which has a major regulatory role in the breakdown of glycogen. The two types of PhK deficiency are liver PhK deficiency (characterized by early childhood onset of hepatomegaly and growth restriction, and often, but not always, fasting ketosis and hypoglycemia) and muscle PhK deficiency, which is considerably rarer (characterized by any of the following: exercise intolerance, myalgia, muscle cramps, myoglobinuria, and progressive muscle weakness). While symptoms and biochemical abnormalities of liver PhK deficiency were thought to improve with age, it is becoming evident that affected individuals need to be monitored for long-term complications such as liver fibrosis and cirrhosis.</Attribute>
                <XRef ID="NBK55061" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21634085</ID>
                <ID Source="BookShelf">NBK55061</ID>
              </Citation>
              <XRef ID="264580" DB="Orphanet" />
              <XRef ID="C2751643" DB="MedGen" />
              <XRef ID="MONDO:0013091" DB="MONDO" />
              <XRef Type="MIM" ID="613027" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1585857" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2018-10-10">
        <ClinVarSubmissionID localKey="4173011|MedGen:C2751643" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000813708" DateUpdated="2024-02-14" DateCreated="2018-10-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-04-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8896567</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17689125</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21646031</ID>
          </Citation>
          <Comment>This variant has not been reported in the literature in individuals with PHKG2-related disease. Loss-of-function variants in PHKG2 are known to be pathogenic (PMID: 8896567, 17689125, 21646031). For these reasons, this variant has been classified as Pathogenic. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Val84Serfs*26) in the PHKG2 gene. It is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PHKG2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.30762580del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2751643" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB4474525</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1585857" TraitType="Disease" MappingType="XRef" MappingValue="C2751643" MappingRef="MedGen">
        <MedGen CUI="C2751643" Name="Glycogen storage disease IXc" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

